RBC Europe’s Lineage Cell Therapeutics LCTX Stock Holding History

RBC Europe’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,700	Closed	-$10K	–	1216
2020 Q4	$10K	Hold	5,700	–	–	﹤0.01%	877
2020 Q3	$5.34K	Hold	5,700	–	–	﹤0.01%	899
2020 Q2	$4.96K	Hold	5,700	–	–	﹤0.01%	869
2020 Q1	$4.72K	Hold	5,700	–	–	﹤0.01%	835
2019 Q4	$5.07K	Hold	5,700	–	–	﹤0.01%	900
2019 Q3	$5.59K	Hold	5,700	–	–	﹤0.01%	885
2019 Q2	$6.27K	Hold	5,700	–	–	﹤0.01%	885
2019 Q1	$7.47K	Hold	5,700	–	–	﹤0.01%	876
2018 Q4	$5.2K	Sell	5,700 -815	-13%	-$1.25K	﹤0.01%	919
2018 Q3	$13.4K	Hold	6,515	–	–	﹤0.01%	771
2018 Q2	$11.7K	Buy	+6,515	New	+$13.1K	﹤0.01%	815

Other funds holding LCTX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Two Sigma Advisers

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return